| |
| |
|
| Insider
Information: |
Perlmutter Roger M |
| Relationship: |
Exe V-P & Pres, MRL |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
413,459 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$84,141,285 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
413,459 |
|
|
| Total
Value |
$84,141,285 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
EVP, Research & Develo... |
2012-02-02 |
186,031 |
2003-07-31 |
0 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2012-12-14 |
13,000 |
2009-12-14 |
0 |
Premium* |
|
|
Merck & Co Inc |
MRK |
Exe V-P & Pres, MRL |
2020-02-28 |
214,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-11-08 |
4 |
S |
$75.27 |
$16,967,967 |
D/D |
(225,443) |
141,555 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-11-08 |
4 |
OE |
$44.98 |
$10,140,426 |
D/D |
225,443 |
366,998 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-11-17 |
4 |
OE |
$58.69 |
$5,868,750 |
D/D |
100,000 |
148,281 |
|
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-11-17 |
4 |
S |
$82.19 |
$5,352,490 |
D/D |
(65,000) |
83,281 |
|
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2012-02-02 |
4 |
S |
$69.83 |
$5,237,325 |
D/D |
(75,000) |
186,031 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2012-02-02 |
4 |
OE |
$58.61 |
$4,395,750 |
D/D |
75,000 |
261,031 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2009-06-02 |
4 |
S |
$51.07 |
$4,340,865 |
D/D |
(85,000) |
149,192 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2009-06-02 |
4 |
OE |
$38.36 |
$3,260,600 |
D/D |
85,000 |
234,192 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-11-17 |
4 |
S |
$82.19 |
$2,880,584 |
D/D |
(35,000) |
48,281 |
|
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2020-02-28 |
4 |
A |
$76.56 |
$2,683,351 |
D/D |
35,049 |
214,428 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$2,647,476 |
D/D |
32,937 |
175,336 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-07-27 |
4 |
S |
$80.86 |
$2,632,468 |
D/D |
(32,500) |
55,781 |
|
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2017-02-27 |
4 |
A |
$65.85 |
$2,151,320 |
D/D |
32,670 |
101,601 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-02-27 |
4 |
A |
$54.72 |
$1,911,424 |
D/D |
34,931 |
138,907 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2003-07-31 |
4 |
S |
$70.80 |
$1,770,000 |
D/D |
(25,000) |
67,750 |
|
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2007-05-11 |
4 |
D |
$54.25 |
$1,556,107 |
D/D |
(28,684) |
82,295 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-07-27 |
4 |
OE |
$38.36 |
$1,534,400 |
D/D |
40,000 |
88,281 |
|
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2016-05-06 |
4 |
D |
$54.09 |
$1,457,509 |
D/D |
(26,946) |
67,953 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2016-02-22 |
4 |
A |
$50.77 |
$1,280,775 |
D/D |
25,227 |
50,227 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2008-05-12 |
4 |
D |
$41.86 |
$1,122,141 |
D/D |
(26,807) |
128,146 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2003-07-31 |
4 |
OE |
$38.36 |
$959,000 |
D/D |
25,000 |
92,750 |
|
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-04-01 |
4 |
D |
$57.35 |
$629,646 |
D/D |
(10,979) |
48,281 |
|
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2005-07-27 |
4 |
S |
$81.16 |
$592,830 |
D/D |
(7,300) |
48,481 |
|
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2004-04-01 |
4 |
D |
$58.64 |
$497,854 |
D/D |
(8,490) |
59,260 |
|
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-03-11 |
4 |
D |
$51.84 |
$423,999 |
D/D |
(8,179) |
174,302 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
